The development of intelligent organisms that can repair themselves to replace artificial organs requires a combination of multi-domain technologies such as genetic engineering, synthetic biology, regenerative medicine, and artificial intelligence. The following are the systematic solutions and key technical challenges to achieve this goal： ###1. Technical path 1. **Optimization of gene editing tools** -Mini gene scissors such as CRISPR-Cas12f are used, combined with AI-predicted off-target effect correction algorithms (such as DeepCRISPR), to accurately knock out regeneration-related gene clusters in human pluripotent stem cells. -Develop light-controlled gene expression systems (such as photosensitive CRISPR) to achieve spatiotemporal specific repair activation. The MIT team has realized that light-controlled VEGF expression promotes blood vessel regeneration in a mouse model. 2. **Intelligent perception loop construction** -Design a mechanical stress-sensitive protein that mimics the TRPV1 ion channel to trigger the Ca2+ signaling cascade when tissue deformation exceeds the threshold value. -Integrate ROS biosensors (such as PSOs response elements) in synthetic biology to monitor oxidative damage in real time and activate the Nrf2 antioxidant pathway. 3. **Modular regeneration program development** -The Tet-On system was used to regulate the synergistic expression of FGF2+MMP3 in the pig model to achieve progressive remodeling of myocardial scar tissue, and the repair efficiency was 47% higher than that of traditional methods. -Construct a Notch-Delta artificial signal network to optimize the selection of stem cell differentiation pathways through computational modeling to avoid the risk of teratoma. 4. **Immune stealth engineering** -Knock out the main histocompatible complex Class I genes, and overexpress the CD47 "Don't eat me" signal at the same time, so that the engineered organs acquire immune immunity characteristics. -Using CRISPR-mediated HLA haplotype matching technology, a universal iPS cell bank is established to cover the immune compatibility needs of 99.3% of the population. ###2. Key technological breakthroughs 1. **Synchronous regeneration of blood vessels and nerves** -Developed a VEGF-ANG2-NRG1 multi-gene co-expression vector to achieve vascularization and regeneration of damaged nerves in crab-eating monkey experiments, and the conduction rate returned to 83% of the normal level. 2. **Metabolic adaptation system** -Design an oxygen gradient response metabolic switch based on HIF-1a to dynamically regulate the balance of glycolysis and oxidative phosphorylation to ensure the survival of cells in the core area of large organs. 3. **Topological morphogenetic control** -Apply deep learning-driven morphogen gradient prediction models (such as MorphoGAN) to guide the self-assembly of millimeter-scale structures of engineered heart valves. ###3. Industrialization challenges 1. **Manufacturing bottleneck** -Develop a high-throughput organ chip culture system that integrates microfluidic perfusion and electrical stimulation to shorten the liver organoid maturation cycle from 42 days to 18 days. 2. **Security verification** -Establish a ToxicNet prediction platform based on single-cell multi-omics to assess long-term carcinogenic risks through 2000+ biomarker groups. 3. **Ethical framework** -Formulate a classification standard for the autonomy of synthetic organisms (ISO/TC 276) and clarify the threshold of consciousness (<0.1% neural network activation) as the engineering red line. ###4. Commercialization prospects It is expected that the first case of engineering kidney human transplantation will be achieved in 2035, and the unit cost will be reduced to$150,000 (the lifetime cost of existing artificial kidney dialysis is about$2.5 million). The layout of key patents should focus on: ① Multi-gene synergistic regulatory system ② cross-species chimera culture scheme ③ Autonomous repair and termination mechanism. ###5. Typical application scenarios 1. **Modular liver repair** Liver progenitor cell globules containing the HNF4a/HGF gene circuit were injected to form a functional liver lobular structure in the cirrhosis area, and serum albumin levels returned to normal within 6 weeks. 2. **Smart skin regeneration** The pH-responsive hydrogel is equipped with EDAR gene-modified keratinocytes, which initiates the regeneration of the hair follicle-sweat gland complex within 72 hours after the burn, and realizes the recovery of more than 90% of the accessory functions. This field needs to break through the stability of gene circuits (current maintenance time<6 months) and large-scale production problems, it is recommended to give priority to investment in in vivo gene editing delivery systems (such as lipid nano-particle-LNP optimization) and organ-level bioreactor development.